Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesAbsence of VOD in paediatric thalassemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan
British Journal of Haematology, 09/14/09
Cappelli B et al. – Oral defibrotide prophylaxis and i.v. busulphan safely abated VOD incidence in high–risk patients who had undergone HSCT. A galenic preparation of oral DF also permits this treatment in low–weight patients. Costs of DF prophylaxis are acceptable considering the reduced incidence of VOD.
Related Articles
The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity
Blood Coagulation & Fibrinolysis, 11/03/09
Relevance Score: 45%
Primary Antifungal Prophylaxis in Adult Hematopoietic Stem Cell Transplant Recipients: Current Therapeutic Concepts
Pharmacotherapy, 10/29/09
Relevance Score: 45%
A Model-based Assessment of Oseltamivir Prophylaxis Strategies to Prevent Influenza in Nursing Homes
Emerging Infectious Diseases, 10/16/09
Relevance Score: 45%
Sodium Bicarbonate Plus N-Acetylcysteine Prophylaxis
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/20/09
Relevance Score: 43%
Athletic Participation in Severe Hemophilia: Bleeding and Joint Outcomes in Children on Prophylaxis
Pediatrics, 11/02/09
Relevance Score: 43%
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Peripheral arterial tonometry in assessing endothelial dysfunction in pediatric sickle cell disease
Pediatric Hematology and Oncology, 11/25/09
Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature
Pediatric Hematology and Oncology, 11/25/09
Src tyrosine kinase pre-activation is associated with platelet hypersensitivity in essential thrombocythemia and polycythemia vera
Blood, 11/25/09
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II study
Bone Marrow Transplantation, 11/25/09
Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention
British Journal of Haematology, 11/25/09
Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions
British Journal of Haematology, 11/25/09
Today in Pediatric Heme/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Peripheral arterial tonometry in assessing endothelial dysfunction in pediatric sickle cell disease
Pediatric Hematology and Oncology, 11/25/09
Hepatoblastoma metastatic to the right atrium responding to chemotherapy alone
Pediatric Hematology and Oncology, 11/25/09
Association between defb1 gene haplotype and herpes viruses seroprevalence in children with acute lymphoblastic leukemia
Pediatric Hematology and Oncology, 11/25/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
Oncogene, 11/25/09
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
Investigational New Drugs, 11/25/09
Adding more content to screening: reactivation of FOXO as a therapeutic strategy
Clinical and Translational Oncology, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor